HeadlinesBriefing favicon HeadlinesBriefing

Private Equity 24 Hours

×
25 articles summarized · Last updated: LATEST

Last updated: June 12, 2026, 5:31 PM ET

Private‑Market Deal Flow

Enterprise software and blockchain firms dominated the week’s largest raises, with U.S. company Ninja One securing a $400M round that eclipsed all other single‑deal financings in the country, while Digital Asset, a blockchain infrastructure provider, also pulled in significant capital. Across the Atlantic, European operators captured the headline, drawing larger sums and drawing attention to a geographic shift in deal size. The surge in U.S. deals coincides with a broader pivot toward high‑growth tech, yet the European outperformance underscores the continent’s continued appetite for sizable capital injections.

Special‑ty Healthcare Moves

Spectrum Vascular, backed by SK Capital, expanded its footprint by acquiring medical‑device maker Piccolo Medical, adding a portfolio of vascular access and medication‑management products. The transaction signals a trend toward consolidation in niche medical sectors, as firms seek to broaden service lines and scale operations. Meanwhile, KKA‑ and Winterberg‑backed Healthcare Holding Schweiz added Compet Medical, a provider of harm‑reduction and prevention supplies, to its holdings. These deals reflect a growing focus on preventative health and specialized device markets within private‑equity portfolios.

Capital‑raising Momentum

Carlyle announced a target of roughly $15bn for its ninth flagship buyout fund, positioning the firm to compete for high‑yield opportunities in a market where alternative asset managers vie for investor dollars. In parallel, BlackRock capped redemptions on a $13bn private‑credit fund for a second consecutive quarter, a move aimed at preserving liquidity for long‑term borrowers amid a wave of retail‑led exits. The contrasting strategies—expansion of capital commitments versus preservation of existing assets—highlight differing risk appetites among top-tier managers.

SpaceX IPO Reverberations

SpaceX’s planned public offering, projected at a valuation close to $1.8tn, is poised to become the largest IPO ever, delivering a windfall to early investors such as Founders Fund, Sequoia, and Andreessen Horowitz. The announcement is already sparking speculation that a $200bn boom could follow in private markets, as institutional capital seeks to capitalize on high‑growth, high‑visibility ventures. The IPO’s success will also provide a benchmark for European firms, many of whom view SpaceX’s trajectory as a missing piece in their own capital‑raising strategies.

Sector‑Specific Themes

In the pediatric therapy space, a cluster of private‑equity players—including General Atlantic, Aquitaine Capital, Avesi Partners, and PPC Enterprises—has earmarked deals worth over $1.3bn, driven by rising diagnoses of speech disorders in children and the associated demand for early intervention services. This focus on niche therapeutic markets underscores a broader trend of targeting high‑margin, defensible segments that offer long‑term revenue potential. Concurrently, Warburg Pincus is nearing the acquisition of Japanese housing group JSB, a move that signals continued interest in real‑estate assets in Asia where demographic shifts and urbanization pressures are reshaping demand.

Talent and Governance Moves

CalPERS, the largest public pension fund in the United States, promoted Anton Orlich to deputy chief investment officer for private markets following its record private‑equity returns, signaling a renewed emphasis on alternative asset stewardship at the national level. In a separate development, Great Hill Capital appointed former L.E.K. Consulting talent officer Lauren Reddy as head of people, a decision that reflects the growing importance of human‑capital strategies in scaling private‑equity operations. These personnel changes illustrate how firms are investing in internal capabilities to support aggressive growth and deal execution.